The magnetofection method:: Using magnetic force to enhance gene delivery

被引:307
作者
Plank, C
Schillinger, U
Scherer, F
Bergemann, C
Rémy, JS
Krötz, F
Anton, M
Lausier, J
Rosenecker, J
机构
[1] Tech Univ Munich, Inst Expt Oncol, D-81675 Munich, Germany
[2] Chemicell, D-10823 Berlin, Germany
[3] Univ Strasbourg 1, Lab Chim Genet Associe, CNRS, Fac Pharm Strasbourg, F-67401 Illkirch Graffenstaden, France
[4] Univ Munich, Dept Physiol, D-80337 Munich, Germany
[5] Univ Munich, Dept Pediat, D-80337 Munich, Germany
关键词
gene delivery; gene vectors; magnetic drug targeting; magnetic nanoparticles; magnetofection; DNA/TRANSFERRIN-PEI COMPLEXES; DNA COMPLEXES; PLASMID DNA; ADENOVIRUS; THERAPY; EXPRESSION; PARTICLES; MAGNETORECEPTION; TRANSFECTION; VECTORS;
D O I
10.1515/BC.2003.082
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to enhance and target gene delivery we have previously established a novel method, termed magnetofection, which uses magnetic force acting on gene vectors that are associated with magnetic particles. Here we review the benefits, the mechanism and the potential of the method with regard to overcoming physical limitations to gene delivery. Magnetic particle chemistry and physics are discussed, followed by a detailed presentation of vector formulation and optimization work. While magnetofection does not necessarily improve the overall performance of any given standard gene transfer method in vitro, its major potential lies in the extraordinarily rapid and efficient transfection at low vector doses and the possibility of remotely controlled vector targeting in vivo.
引用
收藏
页码:737 / 747
页数:11
相关论文
共 48 条
[31]   Improved method of recombinant AAV2 delivery for systemic targeted gene therapy [J].
Mah, C ;
Fraites, TJ ;
Zolotukhin, I ;
Song, SH ;
Flotte, TR ;
Dobson, J ;
Batich, C ;
Byrne, BJ .
MOLECULAR THERAPY, 2002, 6 (01) :106-112
[32]  
Mertl M, 1999, Science, V283, P775
[33]  
MEYER KB, 1995, GENE THER, V2, P450
[34]   The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells [J].
Ogris, M ;
Steinlein, P ;
Kursa, M ;
Mechtler, K ;
Kircheis, R ;
Wagner, E .
GENE THERAPY, 1998, 5 (10) :1425-1433
[35]   PEGylated DNA/transferrin-PEI complexes:: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery [J].
Ogris, M ;
Brunner, S ;
Schüller, S ;
Kircheis, R ;
Wagner, E .
GENE THERAPY, 1999, 6 (04) :595-605
[36]   Adenovirus-microbead conjugates possess enhanced infectivity: A new strategy for localized gene delivery [J].
Pandori, MW ;
Hobson, DA ;
Sano, T .
VIROLOGY, 2002, 299 (02) :204-212
[37]  
PILGRIMM H, 1999, Patent No. 5916539
[38]  
PLANK C, 1994, J BIOL CHEM, V269, P12918
[39]   Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery [J].
Plank, C ;
Mechtler, K ;
Szoka, FC ;
Wagner, E .
HUMAN GENE THERAPY, 1996, 7 (12) :1437-1446
[40]   Magnetofection:: enhancing and targeting gene delivery by magnetic force in vitro and in vivo [J].
Scherer, F ;
Anton, M ;
Schillinger, U ;
Henkel, J ;
Bergemann, C ;
Krüger, A ;
Gänsbacher, B ;
Plank, C .
GENE THERAPY, 2002, 9 (02) :102-109